Yi Liang
Algemeen Directeur bij BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD.
Oorsprong van het eerstegraads netwerk van Yi Liang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Industrial Machinery | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Yi Liang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Beijing Eastern Chieftain Technology Co., Ltd. | Director/Board Member Chief Executive Officer | ||
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Beijing Liweite Investment Co., Ltd.
 Beijing Liweite Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Liweite Investment Co., Ltd. provides business services. Beijing Liweite Investment Co., Ltd. is based in Beijing, China. The Chinese company was founded in 2009. The CEO is Xue Xian Liang. | Miscellaneous Commercial Services | Director/Board Member | |
| Chinese Pharmaceutical Enterprises Association | Corporate Officer/Principal | ||
| CISEN PHARMACEUTICAL CO., LTD. | Medical Specialties | Director/Board Member | |
Orient Fund Management Co., Ltd.
 Orient Fund Management Co., Ltd. Investment ManagersFinance Orient Fund Management Co., Ltd. (Orient FM) is the fund management subsidiary of Northeast Securities Co., Ltd. (SHE: 000686) in China. Founded in 2004, Orient FM is headquartered in Beijing and manages open-end mutual funds for private individuals. | Investment Managers | Portfolio Manager-Equities | |
| JOINTO ENERGY INVESTMENT CO., LTD. HEBEI | Electric Utilities | Director/Board Member | |
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Guangzhou Longest Science & Technology Co. Ltd.
 Guangzhou Longest Science & Technology Co. Ltd. Medical SpecialtiesHealth Technology Guangzhou Longest Science & Technology Co., Ltd. engages in research, development, manufacture and sale of physiotherapy and medical aesthetics devices. Its products include radial extracorporeal shockwave therapy, interference and vacuum therapy, magnet therapy, pressotherapy, intense pulsed light and other types of medical aesthetics devices. The company was founded on January 26, 2000 by Luo Yuan Long and is headquartered in Guangzhou, China. | Medical Specialties | Chief Executive Officer | |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Pharmaceuticals: Major | Director/Board Member | |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
| Nankai University | College/University | Masters Business Admin | |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Dizal Pharma
 Dizal Pharma BiotechnologyHealth Technology Dizal Pharma is a Chinese biotechnology company that operates in an undisclosed location. The company was founded in 2017, and its CEO is Xiao Lin Zhang. | Biotechnology | Director/Board Member | |
| Tianjin University | College/University | Undergraduate Degree |
Statistieken
Internationaal
| China | 17 |
Sectoraal
| Health Technology | 8 |
| Commercial Services | 4 |
| Consumer Services | 3 |
| Finance | 2 |
| Utilities | 2 |
Operationeel
| Director/Board Member | 30 |
| Independent Dir/Board Member | 12 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 4 |
| Investor Relations Contact | 3 |
Sterkste connecties
| Insiders | |
|---|---|
| Xue Gong Wang | 9 |
| Fu Qing Wang | 4 |
| Qiang Zhao | 3 |
| Di Liu | 3 |
| Kai Liang | 2 |
| Yi Peng Qiu | 2 |
| Yuan Long Luo | 2 |
| Jian Wang | 1 |
| Jin Ting Zhang | 1 |
| Meng Meng Chu | 1 |
| Xu Jun Li | 1 |
| Yun Xu | 1 |
| Yan Li Fan | 1 |
| Ze Jun Liu | 1 |
| Zhen Hua Lu | 1 |
